1-6 of 6
Shuji Ueda
Close
Sort by
Journal Articles

Elevated Serum Soluble Interleukin-2 Receptor Level Is a Useful Prognostic Factor for Disease-Specific Overall Survival in Patients with Newly Diagnosed Follicular Lymphoma before Initiation of Treatment

Kenji Nozaki, MD, Hiroyuki Sugahara, MD PhD, Shuji Ueda, MD PhD, Jun Ishikawa, MD PhD, Shigeo Fuji, MD PhD, Hiroaki Masaie, MD PhD, Yuma Tada, MD, Makiko Suga, MD, Kazuhito Tsutsumi, MD, Kumi Shibata, MD, Shuhei Kida, MD, Takahiro Karasuno, MD PhD, Hiroshi Sata, MD PhD, Masato Yasumi, MD PhD, Masato Iida, MD PhD, Hideki Mitsui, MD PhD, Tsuyoshi Kamae, MD PhD, Norimitsu Saito, MD PhD, Hiraku Murakami, MD, Yasuhiro Moriyama, MD PhD, Manabu Kawakami, MD PhD, Ruri Kato, MD PhD, Yoshiki Nakae, MD PhD, Toru Kida, MD, Satoru Kosugi, MD PhD, Hirohiko Shibayama, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3985.
https://doi.org/10.1182/blood-2019-126399
Published: 2019
Journal Articles

Clinical Meanings of Quantitative PCR of Patient-Specific Immunoglobulin VDJ Regions Using Various Materials of Myeloma Patients

Hiroshi Sata, Hirohiko Shibayama, Ikuhiro Maeda, Yoko Habuchi, Eiji Nakatani, Kentaro Fukushima, Jiro Fujita, Sachiko Ezoe, Seiji Tadokoro, Tetsuo Maeda, Masao Mizuki, Satoru Kosugi, Masashi Nakagawa, Shuji Ueda, Masato Iida, Yukihiro Tokumine, Hideki Mitsui, Yasuhiko Azenishi, Kenji Oritani, Yuzuru Kanakura, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2049.
https://doi.org/10.1182/blood.V124.21.2049.2049
Published: 2014
Journal Articles

Short Cycle of Immunochemotherapy Followed by Radiation Therapy Compared with Prolonged Cycles of Immunochemotherapy for Localized DLBCL: The Osaka Lymphoma Study Group (OLSG) Retrospective Analysis

Yoshiki Terada, Hironori Take, Hirohiko Shibayama, Koji Hashimoto, Maki Kuwayama, Norie Fujii, Yasuhiko Azenishi, Yasuhiro Maeda, Tamotu Yamagami, Nobuhiko Uoshima, Machiko Tsukaguchi, Osamu Semba, Hideki Mitui, Shuji Ueda, Toshihiro Soma, Masashi Nakagawa, Mituhiro Matuda, Fumiaki Urase, Teruo Kiyoi, Hitoshi Yoshida, Hiroyuki Sugahara, Kenichi Yamashita, Nobuhiko Tominaga, Takeshi Kubota, Nobuyoshi Arima, Shinichirou Mori, Toshiharu Tamaki, Takahiro Okamoto, Naoyuki Anzai, Hiroshi Akasaka, Rie Tabata, Junichiro Ikeda, Naoki Wada, Katsuyuki Aozasa, Masayuki Hino
Journal: Blood
Blood (2012) 120 (21): 1628.
https://doi.org/10.1182/blood.V120.21.1628.1628
Published: 2012
Journal Articles

Necessity of tyrosine 719 and phosphatidylinositol 3′-kinase–mediated signal pathway in constitutive activation and oncogenic potential of c- kit receptor tyrosine kinase with the Asp814Val mutation

Koji Hashimoto, Itaru Matsumura, Tohru Tsujimura, Dae-Ki Kim, Hideki Ogihara, Hirokazu Ikeda, Shuji Ueda, Masao Mizuki, Hiroyuki Sugahara, Hirohiko Shibayama, Yukihiko Kitamura, Yuzuru Kanakura
Journal: Blood
Blood (2003) 101 (3): 1094–1102.
https://doi.org/10.1182/blood-2002-01-0177
Published: 2003
Journal Articles

Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor–induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration

Shuji Ueda, Masao Mizuki, Hirokazu Ikeda, Tohru Tsujimura, Itaru Matsumura, Kazushi Nakano, Hanako Daino, Zen-ichiro Honda, Junko Sonoyama, Hirohiko Shibayama, Hiroyuki Sugahara, Takashi Machii, Yuzuru Kanakura
Journal: Blood
Blood (2002) 99 (9): 3342–3349.
https://doi.org/10.1182/blood.V99.9.3342
Published: 2002
Journal Articles

Induction of apoptosis by extracellular ubiquitin in human hematopoietic cells: possible involvement of STAT3 degradation by proteasome pathway in interleukin 6-dependent hematopoietic cells

Hanako Daino, Itaru Matsumura, Koji Takada, Junko Odajima, Hirokazu Tanaka, Shuji Ueda, Hirohiko Shibayama, Hirokazu Ikeda, Masahiko Hibi, Takashi Machii, Toshio Hirano, Yuzuru Kanakura
Journal: Blood
Blood (2000) 95 (8): 2577–2585.
https://doi.org/10.1182/blood.V95.8.2577
Published: 2000